QA: Evelo Biosciences Inc. in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001694665_2019_Evelo_Biosciences_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001694665')"}

Graph

Absolute values for 0001694665, Evelo Biosciences Inc.

  xvar xval
0 AssetsCurrent 151,622,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 6,925,000
3 remainder_Assets 1,320,000
4 LiabilitiesCurrent 9,235,000
5 LiabilitiesNoncurrent 12,612,000
6 remainder_Liabilities 1,071,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 18,218,000
9 ResearchAndDevelopmentExpense 39,885,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 1,157,000
13 remainder_ComprehensiveNetIncome -18,000
  yvar yval
0 Assets 159,867,000
1 Liabilities 22,918,000
2 Expenses 58,103,000
3 Revenues 0
4 StockholdersEquity 136,949,000
5 NetIncome -56,946,000
6 ComprehensiveNetIncome -56,955,000
7 BaseVar 121,031,500
8 EconomicCapitalRatio 1.95

Edgar->Model Mapping

Feature Distribution

Change over Time